Upgrade to SI Premium - Free Trial

Mallinckrodt (MNK) StrataGraft Designated as Regenerative Medicine Advanced Therapy by U.S. FDA

July 18, 2017 7:02 AM
Mallinckrodt plc (NYSE: MNK), today announced that StrataGraft® regenerative skin tissue is among the first products to be designated as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Next Articles